Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
AEHR filed a Form 144 reporting a proposed sale of 3,500 shares of Common Stock by Fidelity Brokerage Services LLC with an indicated date of 04/10/2026 on NASDAQ. The filing also lists multiple restricted stock vesting events issued by the company: 484 (04/27/2025), 1,159 (07/11/2025), 558 (07/27/2025), 1,157 (10/02/2025) and 142 (10/11/2025).
Aehr Test Systems submitted a Form 144/A reporting the proposed sale of 40,000 shares of Common Stock originally from a Private Placement dated 03/15/2013. The filing lists a table row with the figure 2718978.35 and references NASDAQ with a date 04/09/2026.
AEHR affiliate filed a Form 144 notifying the broker Oppenheimer & Co., Inc. of an intended sale of 30,000 shares of Common Stock, tied to a compensation award dated 11/28/2018. The filing lists an aggregate dollar value of $2,100,000.00 and identifies Nasdaq as the market. The filer, Rhea J Posedel, reported prior sales of 13,998 shares on 02/13/2026 for $390,404.22.
Charles Schwab Corp. filed a Form 144 reporting a proposed sale of Common stock. The notice lists 32,762 shares and an aggregate value of $2,164,585.00, with a Nasdaq listing and a filing date of 04/09/2026.
AEHR submitted a Rule 144 notice regarding transfers of Common stock linked to vested RSUs. The excerpt lists multiple vested RSU lots—500 (10/02/2023), 1,500 (04/01/2024), 528 (10/01/2024) and 1,200 (04/03/2023)—and includes an entry showing 247800.00 and 04/09/2026 with Nasdaq referenced.
AEHR Technology submitted a Form 144 notifying of a proposed sale of 10,582 shares related to an option granted on 04/06/2022, with the sale method listed as Cash on 04/09/2026. The filing also lists multiple prior restricted stock vesting events (234; 233; 254; 691; 254; 612; 225 shares) with their respective dates.
Charles Schwab & Co., Inc. notice of proposed sale: 7,665 Restricted Stock Units are listed for sale under Rule 144.
Reporting person Laura Ann Oliphant shows a prior sale of 4,546 shares on 01/22/2026 with proceeds of $142,717.73. The filing lists broker/record details and identifies the securities as Equity Compensation.
Aehr Test Systems entered into an equity distribution agreement on April 8, 2026 with William Blair & Company and Craig-Hallum Capital Group to sell up to $60,000,000 of common stock through an at-the-market offering program. Sales will be made from time to time under an effective Form S-3 shelf registration and an April 8, 2026 prospectus supplement. The agents will use commercially reasonable efforts to place shares and will receive a commission of up to 3.0% of gross proceeds. Either the company or the agents can suspend or terminate the program upon written notice.
Aehr Test Systems is registering an at-the-market offering to sell up to $60,000,000 of its common stock through an Equity Distribution Agreement with William Blair and Craig-Hallum dated April 8, 2026. The offering may be made from time to time at prevailing market prices and the agents will receive commissions up to 3.00%.
The prospectus supplement states the company may use net proceeds for general corporate purposes including working capital, inventory, research and development, commercial activities and capital expenditures. The company reported 30,953,752 shares outstanding as of February 27, 2026 and referenced a last reported sale price of $52.16 per share on April 6, 2026.